Concert Pharmaceuticals

+$0.06 (+1.54%) Today
$0.00 (0.00%) As of 12:00 PM UTC after-hours

Why Robinhood?

You can buy or sell CNCE and other stocks, options, and ETFs commission-free!

About CNCE

Concert Pharmaceuticals, Inc. Common Stock, also called Concert Pharmaceuticals, is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology.

CEO
Roger D. Tung
Employees
71
Headquarters
Lexington, Massachusetts
Founded
2006

CNCE Key Statistics

Market Cap
126.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
335.45K
High Today
$4.06
Low Today
$3.83
Open Price
$3.88
Volume
279.50K
52 Week High
$13.50
52 Week Low
$3.68

CNCE Earnings

-$0.86
-$0.71
-$0.56
-$0.41
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.69 per share
Actual
-$0.67 per share
Replay Earnings Call

You May Also Like

RBGLY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure